市場調査レポート概要
目次
Description
Table of Contents
Figures
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD TABLE 2 RISK ASSESSMENT: WEARABLE INJECTORS MARKET TABLE 3 TOP FIVE COUNTRIES WITH HIGHEST NUMBER OF DIABETES PATIENTS (20-79 YEARS), 2021 VS. 2045 TABLE 4 RECENT COLLABORATIONS IN WEARABLE INJECTORS MARKET TABLE 5 IMPORT AND EXPORT DATA FOR WEARABLE INJECTORS, BY COUNTRY TABLE 6 PORTER’S FIVE FORCES ANALYSIS: WEARABLE INJECTORS MARKET TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 10 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 11 MIDDLE EAST: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 12 AVERAGE SELLING PRICE OF WEARABLE INJECTORS, BY KEY PLAYERS, 2022 TABLE 13 DETAILED LIST OF KEY CONFERENCES & EVENTS IN WEARABLE INJECTORS MARKET, 2023-2024 TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE DISEASES (%) TABLE 15 KEY BUYING CRITERIA FOR TOP THREE DISEASES TABLE 16 WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 17 WEARABLE INJECTORS MARKET FOR ON-BODY WEARABLE INJECTORS, BY COUNTRY, 2021-2029 (USD MILLION) TABLE 18 WEARABLE INJECTORS MARKET FOR OFF-BODY WEARABLE INJECTORS, BY COUNTRY, 2021-2029 (USD MILLION) TABLE 19 WEARABLE INJECTORS MARKET FOR DEVICE-ONLY WEARABLE INJECTORS, BY COUNTRY, 2021-2029 (USD MILLION) TABLE 20 WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 21 WEARABLE INJECTORS MARKET FOR SPRING-BASED TECHNOLOGY, BY COUNTRY, 2021-2029 (USD MILLION) TABLE 22 WEARABLE INJECTORS MARKET FOR MOTOR-DRIVEN TECHNOLOGY, BY COUNTRY, 2021-2029 (USD MILLION) TABLE 23 WEARABLE INJECTORS MARKET FOR ROTARY PUMP TECHNOLOGY, BY COUNTRY, 2021-2029 (USD MILLION) TABLE 24 WEARABLE INJECTORS MARKET FOR EXPANDING BATTERY TECHNOLOGY, BY COUNTRY, 2021-2029 (USD MILLION) TABLE 25 WEARABLE INJECTORS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2029 (USD MILLION) TABLE 26 WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 27 INSULIN DEVICES AVAILABLE FOR DIABETIC PATIENTS TABLE 28 WEARABLE INJECTORS MARKET FOR DIABETES, BY COUNTRY, 2021-2029 (USD MILLION) TABLE 29 WEARABLE INJECTORS MARKET FOR IMMUNO-ONCOLOGY, BY COUNTRY, 2021-2029 (USD MILLION) TABLE 30 WEARABLE INJECTORS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021-2029 (USD MILLION) TABLE 31 WEARABLE INJECTORS MARKET FOR CHRONIC PAINS, BY COUNTRY, 2021-2029 (USD MILLION) TABLE 32 WEARABLE INJECTORS MARKET FOR OTHER DISEASES, BY COUNTRY, 2021-2029 (USD MILLION) TABLE 33 WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 34 WEARABLE INJECTORS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2029 (USD MILLION) TABLE 35 WEARABLE INJECTORS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021-2029 (USD MILLION) TABLE 36 WEARABLE INJECTORS MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2029 (USD MILLION) TABLE 37 WEARABLE INJECTORS MARKET, BY REGION, 2021-2029 (USD MILLION) TABLE 38 NORTH AMERICA: WEARABLE INJECTORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION) TABLE 39 NORTH AMERICA: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 40 NORTH AMERICA: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 41 NORTH AMERICA: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 42 NORTH AMERICA: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 43 US: KEY MACROINDICATORS TABLE 44 US: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 45 US: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 46 US: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 47 US: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 48 CANADA: KEY MACROINDICATORS TABLE 49 CANADA: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 50 CANADA: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 51 CANADA: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 52 CANADA: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 53 EUROPE: WEARABLE INJECTORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION) TABLE 54 EUROPE: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 55 EUROPE: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 56 EUROPE: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 57 EUROPE: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 58 GERMANY: KEY MACROINDICATORS TABLE 59 GERMANY: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 60 GERMANY: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 61 GERMANY: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 62 GERMANY: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 63 FRANCE: KEY MACROINDICATORS TABLE 64 FRANCE: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 65 FRANCE: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 66 FRANCE: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 67 FRANCE: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 68 UK: KEY MACROINDICATORS TABLE 69 UK: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 70 UK: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 71 UK: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 72 UK: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 73 ITALY: MACROECONOMIC INDICATORS TABLE 74 ITALY: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 75 ITALY: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 76 ITALY: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 77 ITALY: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 78 SPAIN: MACROECONOMIC INDICATORS TABLE 79 SPAIN: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 80 SPAIN: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 81 SPAIN: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 82 SPAIN: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 83 REST OF EUROPE: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 84 REST OF EUROPE: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 85 REST OF EUROPE: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 86 REST OF EUROPE: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 87 ASIA PACIFIC: WEARABLE INJECTORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION) TABLE 88 ASIA PACIFIC: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 89 ASIA PACIFIC: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 90 ASIA PACIFIC: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 91 ASIA PACIFIC: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 92 JAPAN: MACROECONOMIC INDICATORS TABLE 93 JAPAN: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 94 JAPAN: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 95 JAPAN: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 96 JAPAN: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 97 CHINA: MACROECONOMIC INDICATORS TABLE 98 CHINA: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 99 CHINA: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 100 CHINA: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 101 CHINA: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 102 INDIA: MACROECONOMIC INDICATORS TABLE 103 INDIA: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 104 INDIA: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 105 INDIA: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 106 INDIA: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 107 AUSTRALIA: MACROECONOMIC INDICATORS TABLE 108 AUSTRALIA: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 109 AUSTRALIA: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 110 AUSTRALIA: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 111 AUSTRALIA: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 112 SOUTH KOREA: KEY MACROINDICATORS TABLE 113 SOUTH KOREA: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 114 SOUTH KOREA: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 115 SOUTH KOREA: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 116 SOUTH KOREA: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 117 REST OF ASIA PACIFIC: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 118 REST OF ASIA PACIFIC: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 119 REST OF ASIA PACIFIC: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 120 REST OF ASIA PACIFIC: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 121 LATIN AMERICA: WEARABLE INJECTORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION) TABLE 122 LATIN AMERICA: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 123 LATIN AMERICA: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 124 LATIN AMERICA: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 125 LATIN AMERICA: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 126 BRAZIL: MACROECONOMIC INDICATORS TABLE 127 BRAZIL: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 128 BRAZIL: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 129 BRAZIL: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 130 BRAZIL: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 131 MEXICO: KEY MACROINDICATORS TABLE 132 MEXICO: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 133 MEXICO: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 134 MEXICO: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 135 MEXICO: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 136 REST OF LATIN AMERICA: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 137 REST OF LATIN AMERICA: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 138 REST OF LATIN AMERICA: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 139 REST OF LATIN AMERICA: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 140 MIDDLE EAST & AFRICA: WEARABLE INJECTORS MARKET, BY REGION, 2021-2029 (USD MILLION) TABLE 141 MIDDLE EAST & AFRICA: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 142 MIDDLE EAST & AFRICA: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 143 MIDDLE EAST & AFRICA: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 144 MIDDLE EAST & AFRICA: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 145 GCC COUNTRIES: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 146 GCC COUNTRIES: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 147 GCC COUNTRIES: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 148 GCC COUNTRIES: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 149 REST OF MIDDLE EAST & AFRICA: WEARABLE INJECTORS MARKET, BY TYPE, 2021-2029 (USD MILLION) TABLE 150 REST OF MIDDLE EAST & AFRICA: WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION) TABLE 151 REST OF MIDDLE EAST & AFRICA: WEARABLE INJECTORS MARKET, BY INDICATION, 2021-2029 (USD MILLION) TABLE 152 REST OF MIDDLE EAST & AFRICA: WEARABLE INJECTORS MARKET, BY END USER, 2021-2029 (USD MILLION) TABLE 153 LIST OF KEY MANUFACTURERS OF WEARABLE DEVICES TABLE 154 WEARABLE INJECTORS MARKET: OVERALL FOOTPRINT TABLE 155 WEARABLE INJECTORS MARKET: PRODUCT FOOTPRINT TABLE 156 WEARABLE INJECTORS MARKET: REGIONAL FOOTPRINT TABLE 157 DETAILED LIST OF KEY START-UPS/SMES TABLE 158 BRAND/PRODUCT COMPARISON OF KEY PLAYERS TABLE 159 FUNDING IN WEARABLE INJECTORS MARKET, BY INDICATION TABLE 160 WEARABLE INJECTORS MARKET: PRODUCT LAUNCHES & APPROVALS, 2020-2024 TABLE 161 WEARABLE INJECTORS MARKET: DEALS, 2020-2024 TABLE 162 WEARABLE INJECTORS MARKET: OTHER DEVELOPMENTS, 2020-2024 TABLE 163 AMGEN INC.: COMPANY OVERVIEW TABLE 164 AMGEN INC.: DEALS, 2020-2024 TABLE 165 AMGEN INC.: OTHER DEVELOPMENTS, 2020-2024 TABLE 166 MEDTRONIC: COMPANY OVERVIEW TABLE 167 MEDTRONIC: PRODUCT LAUNCHES & APPROVALS, 2020-2024 TABLE 168 MEDTRONIC: DEALS, 2020-2024 TABLE 169 INSULET CORPORATION: COMPANY OVERVIEW TABLE 170 INSULET CORPORATION: PRODUCT LAUNCHES & APPROVALS, 2020-2024 TABLE 171 INSULET CORPORATION: DEALS, 2020-2024 TABLE 172 TANDEM DIABETES CARE, INC.: COMPANY OVERVIEW TABLE 173 TANDEM DIABETES CARE, INC.: DEALS, 2020-2024 TABLE 174 UNITED THERAPEUTICS CORPORATION: COMPANY OVERVIEW TABLE 175 UNITED THERAPEUTICS CORPORATION: DEALS, 2020-2024 TABLE 176 ABBVIE INC.: COMPANY OVERVIEW TABLE 177 ABBVIE INC.: PRODUCT LAUNCHES & APPROVALS, 2020-2024 TABLE 178 GERRESHEIMER AG: COMPANY OVERVIEW TABLE 179 GERRESHEIMER AG: PRODUCT LAUNCHES & APPROVALS, 2020-2024 TABLE 180 GERRESHEIMER AG: DEALS, 2020-2024 TABLE 181 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW TABLE 182 BECTON, DICKINSON AND COMPANY: DEALS, 2020-2024 TABLE 183 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS, 2020-2024 TABLE 184 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY OVERVIEW TABLE 185 YPSOMED HOLDING AG: COMPANY OVERVIEW TABLE 186 YPSOMED HOLDING AG: PRODUCT LAUNCHES & APPROVALS, 2020-2024 TABLE 187 YPSOMED HOLDING AG: DEALS, 2020-2024 TABLE 188 YPSOMED HOLDING AG: OTHER DEVELOPMENTS, 2020-2024 TABLE 189 ENABLE INJECTIONS: COMPANY OVERVIEW TABLE 190 ENABLE INJECTIONS: PRODUCT LAUNCHES & APPROVALS, 2020-2024 TABLE 191 ENABLE INJECTIONS: DEALS, 2020-2024 TABLE 192 ENABLE INJECTIONS: OTHER DEVELOPMENTS, 2020-2024 TABLE 193 SUBCUJECT APS: COMPANY OVERVIEW TABLE 194 CEQUR SIMPLICITY: COMPANY OVERVIEW TABLE 195 CEQUR SIMPLICITY: OTHER DEVELOPMENTS, 2020-2024 TABLE 196 MANNKIND CORPORATION: COMPANY OVERVIEW TABLE 197 MANNKIND CORPORATION: DEALS, 2020-2024 TABLE 198 MANNKIND CORPORATION: OTHER DEVELOPMENTS, 2020-2024 TABLE 199 SONCEBOZ: COMPANY OVERVIEW TABLE 200 CC BIO: COMPANY OVERVIEW TABLE 201 CC BIO: DEALS, 2020-2024 TABLE 202 ELCAM DRUG DELIVERY DEVICES: COMPANY OVERVIEW TABLE 203 ELCAM DRUG DELIVERY DEVICES: DEALS, 2020-2024 TABLE 204 STEVANATO GROUP: COMPANY OVERVIEW TABLE 205 DEBIOTECH SA: COMPANY OVERVIEW
FIGURE 1 RESEARCH DESIGN FIGURE 2 PRIMARY SOURCES FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: AMGEN INC FIGURE 8 SUPPLY-SIDE ANALYSIS OF TOP COMPANIES: WEARABLE INJECTORS MARKET (2022) FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES, 2023-2029 FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS FIGURE 11 TOP-DOWN APPROACH FIGURE 12 MARKET DATA TRIANGULATION FIGURE 13 WEARABLE INJECTORS MARKET, BY TYPE, 2023 VS. 2029 (USD MILLION) FIGURE 14 WEARABLE INJECTORS MARKET, BY TECHNOLOGY, 2023 VS. 2029 (USD MILLION) FIGURE 15 WEARABLE INJECTORS MARKET, BY INDICATION, 2023 VS. 2029 (USD MILLION) FIGURE 16 WEARABLE INJECTORS MARKET, BY END USER, 2023 VS. 2029 (USD MILLION) FIGURE 17 REGIONAL SNAPSHOT OF WEARABLE INJECTORS MARKET FIGURE 18 INCREASING PREVALENCE OF CHRONIC DISEASES AND RISING HEALTHCARE EXPENDITURE TO DRIVE MARKET FIGURE 19 CHINA AND HOSPITALS AND CLINICS ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022 FIGURE 20 US TO REGISTER HIGHEST MARKET GROWTH RATE DURING FORECAST PERIOD FIGURE 21 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD FIGURE 22 DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES: WEARABLE INJECTORS MARKET FIGURE 23 SUPPLY CHAIN ANALYSIS: WEARABLE INJECTORS MARKET FIGURE 24 VALUE CHAIN ANALYSIS: WEARABLE INJECTORS MARKET FIGURE 25 ECOSYSTEM MARKET/MAP: WEARABLE INJECTORS MARKET FIGURE 26 PATENT PUBLICATION TRENDS (JANUARY 2018-MAY 2023) FIGURE 27 TOP APPLICANT COMPANIES FOR WEARABLE INJECTOR PATENTS, 2018-2023 FIGURE 28 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR WEARABLE INJECTOR PATENTS, 2018-2023 FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE DISEASES FIGURE 30 KEY BUYING CRITERIA FOR TOP THREE DISEASES FIGURE 31 ADJACENT MARKETS TO WEARABLE INJECTORS MARKET FIGURE 32 WEARABLE INJECTORS MARKET: REGIONAL SNAPSHOT FIGURE 33 NORTH AMERICA: WEARABLE INJECTORS MARKET SNAPSHOT FIGURE 34 ASIA PACIFIC: WEARABLE INJECTORS MARKET SNAPSHOT FIGURE 35 STRATEGIES ADOPTED BY KEY PLAYERS IN WEARABLE INJECTORS MARKET, 2020-2024 FIGURE 36 REVENUE SHARE ANALYSIS OF KEY PLAYERS, 2018-2022 FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022 FIGURE 38 COMPANY EVALUATION MATRIX, 2022 FIGURE 39 START-UP/SME EVALUATION MATRIX, 2022 FIGURE 40 R&D EXPENDITURE OF KEY PLAYERS, 2021 VS. 2022 FIGURE 41 FUNDING IN WEARABLE INJECTORS MARKET SOARED IN 2022 FIGURE 42 MOST VALUED WEARABLE INJECTORS FIRMS IN 2022 (USD BILLION) FIGURE 43 FINANCIAL METRICS OF KEY COMPANIES, 2022 FIGURE 44 AMGEN INC.: COMPANY SNAPSHOT (2022) FIGURE 45 MEDTRONIC: COMPANY SNAPSHOT (2022) FIGURE 46 INSULET CORPORATION: COMPANY SNAPSHOT (2022) FIGURE 47 TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT (2022) FIGURE 48 UNITED THERAPEUTICS CORPORATION: COMPANY SNAPSHOT (2022) FIGURE 49 ABBVIE INC.: COMPANY SNAPSHOT (2022) FIGURE 50 GERRESHEIMER AG: COMPANY SNAPSHOT (2022) FIGURE 51 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) FIGURE 52 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2022) FIGURE 53 YPSOMED HOLDING AG: COMPANY SNAPSHOT (2022) FIGURE 54 MANNKIND CORPORATION: COMPANY SNAPSHOT (2022)
